Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials.
Rosenfeld
Philip J
PJ
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 33136, USA. prosenfeld@med.miami.edu
Shapiro
Howard
H
Tuomi
Lisa
L
Webster
Mary
M
Elledge
Julee
J
Blodi
Barbara
B